Search Results - Herbert A. Fritsche
- Showing 1 - 15 results of 15
-
1
CA 125 in Ovarian Cancer: Advances and Controversy by Herbert A. Fritsche, Robert C. Bast
Published 1998Editorial -
2
-
3
-
4
Clinical utility of serum HER2/neu in monitoring and prediction of progression-free survival in metastatic breast cancer patients treated with trastuzumab-based therapies by Francisco J. Esteva, Carol D Cheli, Herbert A. Fritsche, Monica Fornier, Dennis J. Slamon, Robert Thiel, Diana Lüftner, Farooq Ghani
Published 2005Artigo -
5
Validation of reverse phase protein array for practical screening of potential biomarkers in serum and plasma: Accurate detection of CA19‐9 levels in pancreatic cancer by Tobias Grote, Doris R. Siwak, Herbert A. Fritsche, Corwin Joy, Gordon B. Mills, Diane M. Simeone, David C. Whitcomb, Craig D. Logsdon
Published 2008Artigo -
6
-
7
-
8
Urinary mesothelin provides greater sensitivity for early stage ovarian cancer than serum mesothelin, urinary hCG free beta subunit and urinary hCG beta core fragment by Donna Badgwell, Zhen Lü, Laurence A. Cole, Herbert A. Fritsche, E. Neely Atkinson, Elizabeth B. Somers, Jeffrey Allard, Richard G. Moore, Karen H. Lu, Robert C. Bast
Published 2007Artigo -
9
Detection and Prognostic Significance of Circulating Tumor Cells in Patients With Metastatic Thyroid Cancer by Jian Xu, Beverly C. Handy, Christina Michaelis, Steven G. Waguespack, Mimi I. Hu, Naifa L. Busaidy, Camilo Jimenez, Maria E. Cabanillas, Herbert A. Fritsche, Gilbert J. Cote, Steven I. Sherman
Published 2016Artigo -
10
Tumor Marker Utility Grading System: a Framework to Evaluate Clinical Utility of Tumor Markers by D. F. Hayes, Robert C. Bast, Christopher E. Desch, Herbert A. Fritsche, Nancy E. Kemeny, J. Milburn Jessup, Gershon Y. Locker, J. S. Macdonald, Robert Mennel, Larry Norton, Peter M. Ravdin, Sheila E. Taube, R Winn
Published 1996Revisão -
11
-
12
Circulating Tumor Cells: A Novel Prognostic Factor for Newly Diagnosed Metastatic Breast Cancer by Massimo Cristofanilli, Daniel F. Hayes, G. Thomas Budd, Mathew J. Ellis, Alison Stopeck, James M. Reuben, Gerald V. Doyle, Jeri Matera, W. Jeffrey Allard, Michael Craig Miller, Herbert A. Fritsche, Gabriel N. Hortobágyi, Leon W.M.M. Terstappen
Published 2005Artigo -
13
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Liver, Bladder, Cervical, and Gastric Cancers by Catharine M. Sturgeon, Michael J. Duffy, Barry R Hofmann, R. Lamerz, Herbert A. Fritsche, Katja N. Gaarenstroom, Johannes M.G. Bonfrèr, Thorsten Ecke, H. Barton Grossman, Peter Hayes, Ralf‐Thorsten Hoffmann, Seth P. Lerner, F. Löhe, Johanna Louhimo, Ihor S. Sawczuk, Kazuhisa Taketa, Eleftherios P. Diamandis
Published 2010Artigo -
14
Interleukin-10 levels are often elevated in serum of adults with Hodgkin's disease and are associated with inferior failure-free survival by A H Sarris, K. O. Kliche, P. Pethambaram, A. Preti, Søren M. Bentzen, Clotilde M. Jackow, Osvaldo Daniel Messina, William Pugh, Fredrick B. Hagemeister, Peter McLaughlin, Maria Alma Rodriguez, Jorge Romaguera, Herbert A. Fritsche, Thomas E. Witzig, Madeleine Duvic, M Andreeff, Fernando Cabanillas
Published 1999Artigo -
15
A 2‐stage ovarian cancer screening strategy using the Risk of Ovarian Cancer Algorithm (ROCA) identifies early‐stage incident cancers and demonstrates high positive predictive valu... by Karen H. Lu, Steven J. Skates, Mary Abigail Hernandez, Deepak G. Bedi, Therese B. Bevers, Leroy J. Leeds, Richard G. Moore, C.O. Granai, Steven T. Harris, William Newland, Olasunkanmi Adeyinka, Jeremy R Geffen, Michael T. Deavers, Charlotte C. Sun, Nora Horick, Herbert A. Fritsche, Robert C. Bast
Published 2013Artigo
Search Tools:
Related Subjects
Medicine
Internal medicine
Cancer
Oncology
Biology
Pathology
Breast cancer
Immunology
Chemistry
Chromatography
Circulating tumor cell
Confidence interval
Gastroenterology
Metastasis
Metastatic breast cancer
Ovarian cancer
Antibody
Antigen
Cancer research
Disease
Ecology
Endocrinology
Gynecology
Hazard ratio
Paleontology
Prospective cohort study
Reproducibility
Surgery
Tumor marker
Urinary system